ABOUT US

OUR STORY

In 2013, the Biomaterials and Bioengineering Laboratory of the French National Institute for Health and Medical Research (Inserm UMR 1121), co-directed by our CSO, Dr. Philippe LAVALLE, discovered the antimicrobial properties of the anti-inflammatory coatings we were working on.

Between 2016 and 2018, we worked to develop our technology with the support of SATT Conectus .

In 2019, our CEO, Dr Nihal Engin Vrana, together with 2 collaborators, Dr Philippe Lavalle and Dr Angela Mutschler created SPARTHA Medical and were then incubated at SEMIA.

2020: TEAM UP

In 2020, the team has expanded with a production manager, Ms Cynthia Calligaro; a Business Developer, Dr Pulchérie Matsodoum Nguemté and a CFO, Mr Thierry Mignot.

We have been privileged to gather a multidisciplinary and experienced scientific advisory board.

In 2021, SPARTHA Medical obtained CIR accreditation for research and development (R&D) after scientific and technical expertise.

2021: TEAM UP

At the end of 2021, SPARTHA Medical welcomed 4 new full-time staff:

Dr Baptiste Letellier, as project manager, responsible for collaborative projects,
Ms Lucie Lieu, as an apprentice engineer in biotechnology,
Ms Yijie Li, a PhD candidate in mechanical engineering,
Ms Ribsimé Mesropian, as an apprentice in marketing and communication.